Get more from every video you own.

cQuenced turns a regulated brand’s entire video ecosystem into something its teams can search, question, produce from, measure, and keep current.

Brand teams spend millions creating, reviewing, and approving video content. Most of it gets deployed once. The medium with the highest production cost has the lowest activation rate in the stack.

80%

of approved brand content is rarely or never used in the field.

Source

Veeva Systems. (2025). Veeva Pulse Field Trends Report, 1Q25.

Veeva Pulse aggregates anonymized activity data from pharmaceutical field teams using Veeva CRM, measuring how approved content actually performs in the field, not just what gets created.

We run the software. You approve the work.

cQuenced runs paid engagements today with pharma manufacturers and holding-company agencies.

Your library is indexed once; every request starts from that index and comes back as finished, reviewed work. Your medical, legal, and regulatory review stays where it is, and your library stays where it lives.

Your video library is your most valuable unmanaged asset. cQuenced makes it your highest-performing one.

How teams start

Pharma brand and medical affairs teams

You have approved video you already paid for and no map of it. We turn it into a ranked queue of finished cuts, and when the label changes we update every asset in the library we hold that carries the old line.

Start with the library

Agencies and communications firms

Your client bought one film. We turn it into the channel plan, under your direction, so your people stay on strategy instead of on versioning.

How agencies use this

Every compliance figure we publish can be re-counted

The compliance work runs against published FDA enforcement letters. They are public, the method is written down, and the count moves when FDA publishes.

48

FDA OPDP untitled letters in the corpus

30

Brands in the calibration set

14

Enforcement patterns indexed

Letters issued between September 2025 and August 2026. Corpus as of 2026-08-31.

The corpus covers letters published in a single enforcement year, and one publication date can carry many letters.

These are patterns observed in publicly available promotional video, not a determination that any company has violated any regulation, and FDA has not reviewed them.

Send us one video and a goal

Thirty minutes. We will tell you what is in your library and what we would make from it.

Book 30 minutes